KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Liabilities and Shareholders Equity (2016 - 2025)

Edwards Lifesciences has reported Liabilities and Shareholders Equity over the past 17 years, most recently at $13.7 billion for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $13.7 billion for Q4 2025, up 4.92% from a year ago — trailing twelve months through Dec 2025 was $53.5 billion (up 16.61% YoY), and the annual figure for FY2025 was $13.7 billion, up 4.92%.
  • Liabilities and Shareholders Equity for Q4 2025 was $13.7 billion at Edwards Lifesciences, up from $13.3 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for EW hit a ceiling of $13.7 billion in Q4 2025 and a floor of $7.2 billion in Q1 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $9.2 billion (2023), compared with a mean of $10.1 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: fell 2.47% in 2022 and later surged 39.43% in 2024.
  • Edwards Lifesciences' Liabilities and Shareholders Equity stood at $8.5 billion in 2021, then fell by 2.47% to $8.3 billion in 2022, then increased by 12.91% to $9.4 billion in 2023, then surged by 39.43% to $13.1 billion in 2024, then increased by 4.92% to $13.7 billion in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $13.7 billion (Q4 2025), $13.3 billion (Q3 2025), and $13.5 billion (Q2 2025) per Business Quant data.